Tempus AI Inc.

AI Score

0

Unlock

81.89
-7.55 (-8.44%)
At close: Feb 18, 2025, 3:59 PM
82.94
1.29%
After-hours: Feb 18, 2025, 07:59 PM EST
undefined%
Bid 82.89
Market Cap 12.48B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -5.16
PE Ratio (ttm) -15.87
Forward PE n/a
Analyst Buy
Ask 83
Volume 21,309,160
Avg. Volume (20D) 8,650,110
Open 90.11
Previous Close 89.44
Day's Range 78.80 - 91.28
52-Week Range 22.89 - 91.45
Beta undefined

About TEM

Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-iden...

Sector Healthcare
IPO Date Mar 28, 2012
Employees 2,300
Stock Exchange NASDAQ
Ticker Symbol TEM
Full Company Profile

Analyst Forecast

According to 11 analyst ratings, the average rating for TEM stock is "Buy." The 12-month stock price forecast is $58, which is a decrease of -29.17% from the latest price.

Buy 63.64%
Hold 36.36%
Sell 0.00%
Stock Forecasts
5 days ago
+13.36%
Tempus AI shares are trading higher after the comp... Unlock content with Pro Subscription
1 week ago
+11.85%
Tempus AI shares are trading higher after TD Cowen reinstated a Buy rating on the stock and announced a price target of $74.